Changes in Cross-Sectional Area of the Median Nerve and Body Composition Parameters after Treatment of Acromegaly: 1 year Follow-Up

Objective. Median neuropathy is a common manifestation of acromegaly, although its pathology is uncertain. Changes in levels of growth hormone (GH) and insulin-like growth factor I (IGF-I) and body composition are potential parameters in pathology of median neuropathy in acromegaly. We aimed to asse...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivana Ságová, Daniela Kantárová, Marián Mokáň, Peter Vaňuga
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2022/8766046
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549728999440384
author Ivana Ságová
Daniela Kantárová
Marián Mokáň
Peter Vaňuga
author_facet Ivana Ságová
Daniela Kantárová
Marián Mokáň
Peter Vaňuga
author_sort Ivana Ságová
collection DOAJ
description Objective. Median neuropathy is a common manifestation of acromegaly, although its pathology is uncertain. Changes in levels of growth hormone (GH) and insulin-like growth factor I (IGF-I) and body composition are potential parameters in pathology of median neuropathy in acromegaly. We aimed to assess changes in the cross-sectional area (CSA) of the median nerve and body composition in newly diagnosed acromegalic patients 1 year after treatment and to determine their mutual relationships. Design. This prospective study included 30 patients with newly diagnosed acromegaly and 30 healthy controls matched for age, gender, and body mass index. Physical and laboratory examinations, dual-energy X-ray absorptiometry (DXA), and ultrasound evaluations were performed at baseline and 1 year after initial treatment. Results. The CSA of the median nerve was increased in acromegalic patients compared with controls (13.1 mm2 [12.2–14.9] vs 7.5 mm2 [6.4–8.4], P<0.001). One year after treatment of acromegaly, GH and IGF-I levels decreased significantly. The median nerve CSA was significantly reduced after treatment (11.6 mm2 [10.2–13.1], P<0.001). Reduction of IGF-I levels correlated with a decrease in lean mass and increase in fat mass. The median nerve CSA positively correlated with IGF-I levels (R = 0.492, P=0.006) and lean mass (R = 0.419, P=0.021) in acromegalic patients before treatment. Conclusion. This study demonstrates a reduction in the median nerve CSA 1 year after treatment of acromegaly. These changes are closely associated with a reduction in IGF- I levels and in lean body mass. The enlargement of the median nerve in acromegaly can be reversed with adequate treatment.
format Article
id doaj-art-8bd3ab35009f47ebb7e8ef26646c05e4
institution Kabale University
issn 1687-8345
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-8bd3ab35009f47ebb7e8ef26646c05e42025-02-03T06:08:42ZengWileyInternational Journal of Endocrinology1687-83452022-01-01202210.1155/2022/8766046Changes in Cross-Sectional Area of the Median Nerve and Body Composition Parameters after Treatment of Acromegaly: 1 year Follow-UpIvana Ságová0Daniela Kantárová1Marián Mokáň2Peter Vaňuga3Department of EndocrinologyComenius University Jessenius Faculty of MedicineComenius University Jessenius Faculty of MedicineDepartment of EndocrinologyObjective. Median neuropathy is a common manifestation of acromegaly, although its pathology is uncertain. Changes in levels of growth hormone (GH) and insulin-like growth factor I (IGF-I) and body composition are potential parameters in pathology of median neuropathy in acromegaly. We aimed to assess changes in the cross-sectional area (CSA) of the median nerve and body composition in newly diagnosed acromegalic patients 1 year after treatment and to determine their mutual relationships. Design. This prospective study included 30 patients with newly diagnosed acromegaly and 30 healthy controls matched for age, gender, and body mass index. Physical and laboratory examinations, dual-energy X-ray absorptiometry (DXA), and ultrasound evaluations were performed at baseline and 1 year after initial treatment. Results. The CSA of the median nerve was increased in acromegalic patients compared with controls (13.1 mm2 [12.2–14.9] vs 7.5 mm2 [6.4–8.4], P<0.001). One year after treatment of acromegaly, GH and IGF-I levels decreased significantly. The median nerve CSA was significantly reduced after treatment (11.6 mm2 [10.2–13.1], P<0.001). Reduction of IGF-I levels correlated with a decrease in lean mass and increase in fat mass. The median nerve CSA positively correlated with IGF-I levels (R = 0.492, P=0.006) and lean mass (R = 0.419, P=0.021) in acromegalic patients before treatment. Conclusion. This study demonstrates a reduction in the median nerve CSA 1 year after treatment of acromegaly. These changes are closely associated with a reduction in IGF- I levels and in lean body mass. The enlargement of the median nerve in acromegaly can be reversed with adequate treatment.http://dx.doi.org/10.1155/2022/8766046
spellingShingle Ivana Ságová
Daniela Kantárová
Marián Mokáň
Peter Vaňuga
Changes in Cross-Sectional Area of the Median Nerve and Body Composition Parameters after Treatment of Acromegaly: 1 year Follow-Up
International Journal of Endocrinology
title Changes in Cross-Sectional Area of the Median Nerve and Body Composition Parameters after Treatment of Acromegaly: 1 year Follow-Up
title_full Changes in Cross-Sectional Area of the Median Nerve and Body Composition Parameters after Treatment of Acromegaly: 1 year Follow-Up
title_fullStr Changes in Cross-Sectional Area of the Median Nerve and Body Composition Parameters after Treatment of Acromegaly: 1 year Follow-Up
title_full_unstemmed Changes in Cross-Sectional Area of the Median Nerve and Body Composition Parameters after Treatment of Acromegaly: 1 year Follow-Up
title_short Changes in Cross-Sectional Area of the Median Nerve and Body Composition Parameters after Treatment of Acromegaly: 1 year Follow-Up
title_sort changes in cross sectional area of the median nerve and body composition parameters after treatment of acromegaly 1 year follow up
url http://dx.doi.org/10.1155/2022/8766046
work_keys_str_mv AT ivanasagova changesincrosssectionalareaofthemediannerveandbodycompositionparametersaftertreatmentofacromegaly1yearfollowup
AT danielakantarova changesincrosssectionalareaofthemediannerveandbodycompositionparametersaftertreatmentofacromegaly1yearfollowup
AT marianmokan changesincrosssectionalareaofthemediannerveandbodycompositionparametersaftertreatmentofacromegaly1yearfollowup
AT petervanuga changesincrosssectionalareaofthemediannerveandbodycompositionparametersaftertreatmentofacromegaly1yearfollowup